## CRWV: CoreWeave, Inc. - XLK: Technology

### Executive Summary

No thesis match: PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($73.08)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Coreweave GC McVeety sells $157k in shares**
- Source: Investing.com | 20251205T084100 | Neutral | Relevance: 100%
- Kristen J McVeety, General Counsel of CoreWeave, Inc. (CRWV), sold 2,118 shares of Class A Common Stock for approximately $157,700 on November 26, 2025. These sales were conducted under a Rule 10b5-1 trading plan. This transaction follows recent company news including strong Q3 results, new analyst coverage, and an expanded credit facility, though JPMorgan downgraded the stock due to supply chain delays.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 1, Lowers: 9)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Roth Capital | $110 | $0 | 0% |
| 2025-12-05 | Freedom Capital | $100 | $0 | 0% |
| 2025-11-17 | Goldman Sachs | $105 | $120 | -12% |
| 2025-11-13 | Compass Point | $150 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Roth Capital | init | Buy |
| 2025-12-05 | Freedom Capital | init | Buy |
| 2025-11-17 | Goldman Sachs | main | Neutral |
| 2025-11-13 | Compass Point | init | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Magnetar Financial L: 21.2% (-14.4%)
- FMR, LLC: 6.9% (+7.1%)
- Nvidia Corp         : 6.3% (0.0%)
- Jane Street Group, L: 3.2% (+143.8%)
- Vanguard Group Inc: 1.9% (+109.7%)

### Key Risks

1. High beta (2.61) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. High short interest (19.3%, 1.6 days to cover): squeeze risk or crowded bearish bet.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Momentum building: MRS_20 improving +19.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Revenue growth strong at 135% YoY. Analyst sentiment negative (9 target cuts vs 1 raises). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.1B |
| Beta | 1.00 |
| 52W Range | $33.52 - $187.00 |
| Short Interest | 19.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from -12.0% to 7.7% (+19.8% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 8.0% confirms short-term momentum alignment. AM_20 at 10.1% shows strong absolute momentum above own 20MA. Outperforming sector by 7.4pp, stock-specific strength. Below SMA200 (1.00x), long-term trend not supportive. MACD histogram positive (2.98), confirming momentum. RSI neutral at 48. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.71% (CS: 93) | Strong |
| RSI_14 | 48.3 | Neutral |
| MACD Histogram | 2.98 | Bullish |
| vs SMA20 | 1.101x | Above |
| vs SMA50 | 0.797x | Below |
| vs SMA200 | 1.000x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $88.30
- **Stop Loss:** $73.08 (17.2% risk)
- **Target:** $103.52 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 65
- **Position Value:** $5,739.50
- **Portfolio %:** 5.74%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-03-24 (Est: $-0.68)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.48 | $-0.22 | +54.4% |
| 2025Q2 | $-0.49 | $-0.60 | -21.7% |
| 2025Q1 | $-0.22 | $-1.40 | -538.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*